Category Innovation/ R&D

GAVI: Reducing Prices To Immunise 250 Million Children By 2015

The GAVI Alliance launched a mid-term report this week showing that the public-private partnership is on track to immunise more than 250 million children by 2015 and prevent some four million deaths. GAVI’s CEO said it uses multiple tools to help reduce prices of vaccine and that intellectual property rights do not pose a serious threat to its success.

WHO Fine-Tuning Pandemic Flu Preparedness Strategy, Use Of Industry Contributions

The World Health Organization is putting the finishing touches on an implementation plan for industry's financial participation in the global influenza preparedness strategy. This week the advisory group met to discuss a draft plan presented by the WHO secretariat, which should now come up with a revised version for implementation in early 2014, according to the chair of the advisory group.

Right To Benefits Of Science: Human Rights Meet IP Rights

A seminar on the right to enjoy the benefits of scientific progress and its applications was held at the United Nations last week with panellists exploring the intersection between intellectual property and human rights in the context of public health, agriculture, and the role of flexibilities to achieve balance between private and public interests.

USTR Support Of USITC Ban On Samsung Imports Contrasts With Earlier Position

The Office of the United States Trade Representative (USTR) yesterday approved the US International Trade Commission’s ban on imports of certain electronics from Samsung, based in part on the fact that the patents in the case do not involve standard essential patents (SEPs). By contrast, concern over SEPs was a big reason for the recent White House decision to overturn a USITC finding that Apple had violated Samsung’s patents.